Korro Bio, Inc. (KRRO:NASDAQ) closed at $13.61 on November 13, 2026, down 4.89% on the day. The stock trades 21.6% below its 52-week high of $17.35 and 161.5% above its 52-week low of $5.20. Over the past year, it gained 121.3%. Korro Bio, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, KRRO closed higher on 124 days (49%). Its best day was October 22, 2026 (+29.71%) and its worst was November 13, 2025 (-79.31%). The stock moved 10% or more in a single session 24 times. It opened at least 5% above the previous day's high 3 times.
Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.
Find more stocks like KRRO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.